Linglong Zou*, Xiaolong Zhang, Zhaoyang Zhang, Weiping Shao and Zhongping Lin
DOI: 10.37421/1948-593X.2020.12.227
Over the past ten years, the global market for large molecule therapeutics has rapidly grown for the treatment of a variety of diseases. LBA and LC-MS are two platforms widely used in pharmacokinetic bioanalysis. In this review, we compare LBA and LC-MS and summarize their strengths and limitations. Strategies for platform selection are provided according to the study purpose, study phase, analyte types, assay requirements and other factors.
DOI: 10.37421/1948-593X.2020.12.226
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 